Lars Blumenstein
Impact in
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Protein Structure and Dynamics
- Biochemical and Molecular Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 12
- Protein Kinase Regulation and GTPase Signaling 7
- Biochemical and Molecular Research 5
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Mohammad Reza Ahmadian (8 shared papers)Radovan Dvorský (5 shared papers)Ingrid R. Vetter (4 shared papers)José Baselga (5 shared papers)Mark R. Middleton (3 shared papers)Cornelia Quadt (5 shared papers)Howard A. Burris (3 shared papers)Hope S. Rugo (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (5 papers)Biochemistry (4 papers)Journal of Biological Chemistry (3 papers)FEBS Letters (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Lars Blumenstein
37 papers receiving 1.3k citations
Lars Blumenstein's Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 944
- Genetics 146
- Oncology 347
- Cell Biology 171
- Cancer Research 143
Countries citing papers authored by Lars Blumenstein
This map shows the geographic impact of Lars Blumenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Blumenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Blumenstein more than expected).
Fields of papers citing papers by Lars Blumenstein
This network shows the impact of papers produced by Lars Blumenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Blumenstein. The network helps show where Lars Blumenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Blumenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study Hit paper breakdown → | 2018 | 302 |
| 2 | 2018 | 186 | |
| 3 | 2004 | 123 | |
| 4 | 2004 | 116 | |
| 5 | 2004 | 61 | |
| 6 | 2003 | 59 | |
| 7 | 2007 | 58 | |
| 8 | 2007 | 52 | |
| 9 | 2008 | 46 | |
| 10 | 2021 | 41 | |
| 11 | 2023 | 31 | |
| 12 | 2002 | 30 | |
| 13 | 2015 | 30 | |
| 14 | 2007 | 24 | |
| 15 | 2004 | 22 | |
| 16 | 2006 | 22 | |
| 17 | 2021 | 20 | |
| 18 | 2014 | 19 | |
| 19 | 2020 | 16 | |
| 20 | 2022 | 14 |
About Lars Blumenstein
Lars Blumenstein is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Materials Chemistry and Cell Biology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (12 papers), Advanced Breast Cancer Therapies (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Enzyme Structure and Function (6 papers), Cancer Treatment and Pharmacology (5 papers), Biochemical and Molecular Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Molecular Biology (944 citations), Genetics (146 citations), Oncology (347 citations), Cell Biology (171 citations) and Cancer Research (143 citations). Lars Blumenstein has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Mohammad Reza Ahmadian, Radovan Dvorský, Ingrid R. Vetter, José Baselga, Mark R. Middleton, Cornelia Quadt, Howard A. Burris, Hope S. Rugo, Dejan Juric and Filip Jankú. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Biochemistry, Journal of Biological Chemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.